Search Results - Filip Rob
- Showing 1 - 3 results of 3
-
1
Efficacy and Safety Evaluation of Different Lebrikizumab Dosages in Atopic Dermatitis Patients Over 16 to 24 Weeks: A BIOREP Registry Analysis Autoría: Filip Rob, Martina Kojanová, Jana Třešnák Hercogová, Monika Baláž, Jiří Horažďovský, Yvetta Vantuchová, Marie Jandová, Kateřina Hrazdírová, Miroslav Nečas, David Stuchlík, Jan Říčař, Zdeněk Antal, Spyridon Gkalpakiotis
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Efficacy and safety of lebrikizumab in atopic dermatitis over 24 weeks: An analysis from the BIOREP registry Autoría: Filip Rob, Spyridon Gkalpakiotis, Martina Kojanová, Yvetta Vantuchová, Jarmila Čelakovská, Jiří Horažďovský, Monika Baláž, Miroslav Nečas, David Stuchlík, Petra Cetkovská, Kateřina Hrazdírová, Alena Machovcová, Blanka Pinková, Jana Třešňák Hercogová
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Efficacy, Safety, and Drug Survival During the First Year of Biologic Therapy for Psoriasis in Elderly Versus Younger Patients Autoría: Tereza Sobotkova, Jan Hugo, Miloslav Salavec, Martina Kojanova, Martin Tichy, Miroslav Necas, Alena Machovcova, Martin Cetkovsky, Zdenka Kysilka, Simona Tivadar, Simona Vachatova, Natalie Kunesova, Monika Balaz, Pavlina Prikrylova, Filip Rob
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso